Prophylactic and Therapeutic Vaccines
A novel approach for treatment of cancer
Cancer immunotherapy, including the development of prophylactic and therapeutic vaccines, is considered a novel approach for prevention and treatment of cancer.


Cancer immunotherapy, including the development of prophylactic and therapeutic vaccines, is considered a novel approach for prevention and treatment of cancer.
Mansoor Amiji &
Mayurkumar Kalariya
Department of
Pharmaceutical Sciences
School of Pharmacy
Northeastern University
USA
New tools and innovative developments in technology have played a key role in the field of medicine. One such technology that is enabling great amount of efficiencies in pharmaceutical development is mobile phones. This technology, which has revolutionised sharing of information digitally, has wide applications in the pharmaceutical industry.
Prasanthi Potluri
Editor
Pharma Focus Asia
Millions of adults are diagnosed as obese each year. Many of these people are at risk of developing additional diseases, such as diabetes mellitus. The mechanisms by which obesity leads towards its complications are poorly understood. Recent research points to adipose tissue as the key target to treat obesity-related complications.
Matej Orešič
Research Professor
Systems Biology &
Bioinformatics
VTT Technical Research
Centre
Finland
Specialized Master degree studies such as the “Master in Biotechnology Management” or “Master in Healthcare Management” are now available at some top European and US-American business schools. These specialized programs become increasingly popular as they offer the industry-specific training that is so critical in order to excel in the healthcare sector.
Joachim M Greuel
Adjunct Professor of
Finance & Healthcare
Management
Academic Director
Master in Biotechnology
Management Programmeme
IE Business School
Spain
Contract research organisation is a place to reckon to address the dwindling research and development budgets of big pharmaceuticals; having skill, capabilities and potential to provide services at excellence. Success of these Organisations relies on their competency, human intellect, experience, leadership and business model.
Somesh Sharma
Director
Jubilant Chemsys Ltd.
India
Layer-by-layer encapsulation gives a very stable fine dispersion, so fine that a dollar coin is visible when looked at through the clear dispersion.
Yuri M Lvov
Professor
Eminent Endowed Chair
on Micro & Nanosystems
Institute for
Micromanufacturing
Louisiana Tech
University
Ruston LA, USA
Biologics are inherently different from chemicals drugs in terms of their source, structural complexity, fragility of the active substance, manufacturing, quality control and stability.
Krishan K Tripathi &
Rajneesh Kumar
Department of Biotechnology
Ministry of
Science & Technology
India
Biosimilars can be proved to be analogous to a Reference Medicinal Product (RMP) by employing a set of robust analytical characterisation techniques which basically provides a ‘finger print’ like identification of Critical Quality Attributes (CQAs) and matching them with RMP.
Shaligram S Rane
Sr. General Manager
Quality Assurance
Nilam Diwan
Assistant Manager
Quality Assurance
Om Narayan
Principal Scientist
R & D
Rustom Mody
Executive Vice President
Science & Technology &
Corresponding
With rapid growth of mobile smart phones and discovery of remote diagnostics devices, there are enormous opportunities to use mobile technologies and integrated wireless devices during clinical trials to improve patient’s medication regimen, reduce drop-outs, reduce site visits, and improve clinical data - all contributing to reduced clinical trial cost and improved compliance.
Vikram Marla
CEO
NowPos M-Solutions
India
The IT outsourcing industry has laid down a solid foundation in terms of establishing and providing service and pricing model that can be ramped up to provide value added and highly skilled outsourcing services. Like the IT outsourcing industry in India, the clinical research industry was also established and expanded by home grown organisations. This sector has grown from a BOT (Build Operate and Transfer) model to a BPO and now to the Full Service outsourcing model.
Vijay Moolaveesala
I3 Statprobe, Inc.
UK